Antidepressant_tca | Moderate Risk

Amitriptyline (ENTRIP)

Amitriptyline risk profile, scheduling, and guidance for claims professionals and care workers . Also known as ENTRIP, Amitriptyline Lupin, APX-Amitriptyline, Amitriptyline Viatris 10, AMITRIPTYLINE-WGR and 5 more.

Source: PBS, TGA Updated April 2026

Amitriptyline (brand names: ENTRIP, Amitriptyline Lupin, APX-Amitriptyline, Amitriptyline Viatris 10, AMITRIPTYLINE-WGR and 5 more) is classified as Moderate risk (3 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Tricyclic antidepressant with significant sedation, anticholinergic effects, and cardiac risks.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Moderate (3 points)
  • CNS depressant: May cause sedation, impair driving, and affect work capacity
  • Serotonergic: Risk of serotonin syndrome when combined with other serotonergic drugs
  • PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 PBS listed

Risk Profile

Risk Level Moderate
Risk Points 3
CNS Depressant Yes
Respiratory Risk No

Tricyclic antidepressant with significant sedation, anticholinergic effects, and cardiac risks.

Regulatory and Compliance Guidance

When Amitriptyline appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.

Work capacity impact: As a CNS depressant, Amitriptyline may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

United Kingdom NICE / MHRA / FPM

NICE guidelines recommend certain antidepressants (amitriptyline, duloxetine) for chronic pain management. For personal injury claims, antidepressant prescribing should be assessed for injury relatedness.

UK drug driving laws (Section 5A Road Traffic Act 2006) set specific limits for prescription drugs that cause impairment. Employers and occupational health advisors should assess fitness to work.

Need to assess this medication across your caseload?

Run a full risk assessment including Amitriptyline interactions and compliance checks.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

Book a Demo

Free trial available. No credit card required.

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.